About the News Conference
Leading national infectious disease experts presented final influenza (flu) vaccine coverage data from the 2021-2022 US flu season and discussed the importance of vaccination against flu and pneumococcal disease, particularly among older adults and those with chronic health conditions who are at higher risk for related complications.
Results from a new NFID national survey of US adults were also shared on vaccination attitudes and behaviors, including the impacts of the COVID-19 pandemic, at the 2022 National Foundation for Infectious Diseases (NFID) Influenza/Pneumococcal Disease News Conference on Tuesday, October 4, 2022.
Panelists included: Tamika C. Auguste, MD, ACOG Fellow and Chair, Women’s and Infants’ Services, MedStar Washington Hospital Center; William Schaffner, MD, NFID Medical Director; Patricia (Patsy) A. Stinchfield, RN, MS, CPNP, NFID President (Moderator); Jeb S. Teichman, MD, Retired Pediatrician and Healthcare Executive; and Rochelle P. Walensky, MD, MPH, Centers for Disease Control and Prevention (CDC) Director, with additional expert Alicia M. Fry, MD, MPH, Chief, Epidemiology and Prevention Branch, Influenza Division, CDC.
Press Kit Information
View the conference press release, agenda, panelist bios, as well as related resources below.
Influenza (Flu) Treatment
Flu antiviral drugs can be used to treat flu illness and help prevent serious flu-related complications, including hospitalization and death
Dan’s Story (Pneumonia)
Dan has a chronic health condition. This makes him more likely to get pneumonia. A vaccine may have saved his life.
2025 National Survey on Respiratory Diseases
The 2025 national survey examines attitudes and behaviors regarding flu, RSV, COVID-19, and pneumococcal disease.
Respiratory Immunization Graphics
Graphics and sample social posts to help raise awareness about preventing COVID-19, flu, RSV, and pneumococcal disease